Ładuje się......
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
BACKGROUND: Immune checkpoints target regulatory pathways in T cells that enhance antitumor immune responses and elicit durable clinical responses. As a novel immune checkpoint, CD96 is an attractive key target for cancer immunotherapy. However, there has been no integrative investigation of CD96 in...
Zapisane w:
| Wydane w: | Front Bioeng Biotechnol |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338376/ https://ncbi.nlm.nih.gov/pubmed/32695752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00592 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|